4D Molecular Therapeutics
FDMT
FDMT
89 hedge funds and large institutions have $182M invested in 4D Molecular Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.82% less ownership
Funds ownership: 81.35% → 80.53% (-0.82%)
54% less capital invested
Capital invested by funds: $395M → $182M (-$214M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
89
Holding in Top 10
–
Calls
$1.08M
Puts
$5K
Top Buyers
| 1 | +$9.37M | |
| 2 | +$4.83M | |
| 3 | +$1.95M | |
| 4 |
Millennium Management
New York
|
+$1.38M |
| 5 |
Renaissance Technologies
New York
|
+$1.33M |
Top Sellers
| 1 | -$6.52M | |
| 2 | -$6.24M | |
| 3 | -$5.98M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.73M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.31M |